New lice treatment wins Norway marketing authorisation Aquaculture biotechnology company Benchmark today announced that is had received marketing authorisation from the Norwegian Medicines Agency (NoMA) for its novel lice treatment Ectosan Vet (BMK08) in Norway.
EU setback for novel lice treatment A doubt has been cast over the commercial introduction of Benchmark’s novel sea lice treatment BMK08 after the European Parliament backed a blocking move by a Green MEP.
Novel lice treatment threatened by European Parliament vote The European Parliament will vote tomorrow on a resolution by Irish Green MEP Grace O’Sullivan that could potentially hamper Norwegian marketing authorisation for Benchmark’s BMK08 sea lice treatment.
Sea lice medicine approval ratified in EU law Aquaculture health, genetics and nutrition company Benchmark Holdings today said that the MRL (Maximum Residue Limit) for its novel sea lice treatment BMK08 has been ratified under European Union law.
Benchmark strengthens team to support lice treatment roll-out Benchmark Animal Health has appointed four new staff to support the operation of its CleanTreat water purification system, which is designed for use with its novel BMK08 lice treatment.
Benchmark signs first CleanTreat agreements Aquaculture health, genetics and advanced nutrition company Benchmark Holdings has signed its first customer agreements for the delivery of its CleanTreat water purification system, it announced today.
New lice treatment method close to commercial launch Aquaculture biotechnology company Benchmark is on track to commercially launch its novel lice treatment for salmon in the second quarter of this year, it said in a financial report today.
Benchmark hires manager to lead Norway lice treatment launch Benchmark Animal Health has appointed a senior manager to lead the Norway commercial launch of its sea lice medicine, BMK08, and its associated CleanTreat water purification system later this year.
Higher revenue and lower costs boost Benchmark An 8% year-on-year increase in revenue and a reduction in costs helped salmon industry egg supplier Benchmark Holdings make adjusted EBITDA of £300,000 in the third quarter of its 2020 financial year.
Benchmark launch paves way for CleanTreat in Chile Benchmark, the UK based aquaculture health, genetics and nutrition company, today announced the launch of its new business in Chile.
Farming Today turns spotlight on new sea lice treatment The possible use of a new sea lice treatment in Scotland has been discussed on BBC Radio 4’s Farming Today programme.
Mowi asks to trial new lice drug in Scotland Mowi Scotland has taken a first step towards the use of Benchmark’s lice medicine Ectosan in the country’s salmon farming industry.
New lice treatment now in hands of regulators The arrival of a new salmon lice treatment is a step closer after its maker completed a regulatory dossier on the product as part of the process to win permission to use it.
